Player is loading...

Embed

Embed code

Transcriptions

Note: this content has been automatically generated.
00:00:00
in the rest of Europe to be honest I
00:00:13
think that problem is the data quality i
00:00:17
think that the data quality in large
00:00:19
databases to study I've shown from
00:00:21
England included more than 60,000
00:00:23
patients or per year and I think in a
00:00:27
very large database like we have the
00:00:29
problem our database lots of data are
00:00:31
missing and I think the data quality in
00:00:34
other countries or in other publications
00:00:37
might be not not as good as an hour
00:00:39
population and I think this might be a
00:00:43
reason why the data quality the recent
00:00:46
years is usually better than it was like
00:00:48
1995-96 or in this year's when we didn't
00:00:51
did not focus that much on the data
00:00:54
quality and large databases anything to
00:00:58
do with saturation levels because we
00:01:00
know that for example the UK they had
00:01:02
quite low saturation levels and most
00:01:05
units increase them now but higher
00:01:11
levels
00:01:11
yeah maybe i'm not sure if this really
00:01:15
is the reason because if you look at the
00:01:19
data they already already started in God
00:01:21
increased in nineteen in 2005 and it was
00:01:25
usually time that point in time at least
00:01:28
in my experience when they increase in
00:01:31
situation is not already done it was
00:01:33
little later I think
00:01:49
and i would like to know you have been
00:01:56
comparing the treatment or the incidence
00:02:00
of treatment the treatment criteria the
00:02:02
same over Switzerland and England is it
00:02:04
the same basically saying yes it's
00:02:08
published very frequently and you know
00:02:12
the rapper upstages 125 there can define
00:02:15
quite clearly and it's pretty clear when
00:02:17
you have two should intervene introduced
00:02:20
to a treatment the problem the inner
00:02:23
study has shown is that in the beginning
00:02:25
there they had like cryotherapy and then
00:02:30
they moved to latest therapy and then
00:02:31
they moved to anti-vegf and so all the
00:02:34
data is little mixed and they just put
00:02:36
all this together in ROP treatment and
00:02:39
it's not really clear if it's really
00:02:41
isn't the same point in RP development
00:02:46
when they started the treatment so they
00:02:48
just mix it up but I think in general
00:02:50
the treatment criteria is basically the
00:02:53
same and in Europe in USA in Switzerland
00:02:57
do you do you change thank you for TSM
00:03:06
very important for TNT's nice
00:03:09
presentation is very short question do
00:03:11
you regard to your conclusions do you
00:03:15
adopt your management them based on oh
00:03:18
no no not yet so i think the results are
00:03:21
not reliable enough to adapt right now
00:03:23
that's what I think we should develop a
00:03:26
precise model already defined we want to
00:03:28
screen patients
00:03:29
let's say below 30 weeks or between
00:03:31
below 29 weeks plus patients with
00:03:33
additional criteria like long oxygen
00:03:35
application and so on and then we have
00:03:37
to test this product respectively and we
00:03:40
said if we come up after let's say 2 35
00:03:43
years and say we really do not miss any
00:03:45
patients then I think we couldn't change
00:03:47
the recommendation but now I think it's
00:03:49
too early

Share this talk: 


Conference program

Welcome Words
M. Roth-Kleiner, R. Arlettaz Mieth
10 Jan. 2017 · 9:33 a.m.
526 views
Short Reports Introduction
E. Giannoni, T. Karen, Resp. Lausanne, Zürich
10 Jan. 2017 · 9:38 a.m.
Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 Jan. 2017 · 9:39 a.m.
182 views
Q&A - Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 Jan. 2017 · 9:44 a.m.
102 views
Retinopathy of Prematurity
Roland Gerull, Bern
10 Jan. 2017 · 9:47 a.m.
154 views
Q&A - Retinopathy of Prematurity
Roland Gerull, Bern
10 Jan. 2017 · 9:54 a.m.
Parechovirus Infection: A Rare Cause of Neonatal Encephalitis (in French)
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 Jan. 2017 · 9:59 a.m.
350 views
Q&A - Parechovirus Infection: A Rare Cause of Neonatal Encephalitis
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 Jan. 2017 · 10:04 a.m.
234 views
112 views
Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 Jan. 2017 · 10:17 a.m.
131 views
Q&A - Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 Jan. 2017 · 10:25 a.m.
Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 Jan. 2017 · 10:27 a.m.
Q&A - Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 Jan. 2017 · 10:34 a.m.
Introduction to Christoph Berger's Presentation
C. Kind, R. Gerull, Resp. St.Gallen, Bern
10 Jan. 2017 · 10:37 a.m.
Vertical Infections: An Update
Christoph Berger, Zürich
10 Jan. 2017 · 10:40 a.m.
253 views
Q&A - Vertical Infections: An Update
Christoph Berger, Zürich
10 Jan. 2017 · 11:15 a.m.
Introduction to Eric Giannoni's Presentation
R. Pfister, S. Kämpfen, Resp. Geneva, Basel
10 Jan. 2017 · 11:44 a.m.
Sepsis, Antibiotics and Resistances: Where Are We?
Christoph Bührer, Berlin
10 Jan. 2017 · 2:21 p.m.
145 views
Use and Abuse of Antibiotics in Neonatology
Martin Stocker, Lucerne
10 Jan. 2017 · 2:50 p.m.
291 views
Panel Discussion : Controversies on Use of Antibiotics in Neonatology
Martin Stocker, Christoph Berger, Eric Giannoni, Christoph Bührer
10 Jan. 2017 · 3:10 p.m.
105 views
Introduction to Christoph Bührer's Presentation
Romaine Arlettaz Mieth , Neonatologist, Zürich, President of the Organizing Committee
10 Jan. 2017 · 3:47 p.m.
Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 Jan. 2017 · 3:48 p.m.
416 views
Q&A - Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 Jan. 2017 · 4:16 p.m.
SwissNeoDose Project
Marc Pfister, Ped Pharmacology, UKBB
10 Jan. 2017 · 4:20 p.m.
112 views
Awards (Case of the Year; Milupa; Best Poster Case Report; Best Oral Short Presentation) & Closing Comments
Matthias Roth-Kleiner, CHUV, President of the SSN
10 Jan. 2017 · 4:30 p.m.

Recommended talks

Neonatal red blood cell (RBC) transfusion practices in Switzerland
L. Gosztonyi, C. Rüegger, R. Arlettaz, Neonatology USZ
16 Jan. 2018 · 9:58 a.m.